Nastech Pharmaceutical Company Inc. (NSTK) Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity (BioSpace, 8 January 2008)

"Adolescent endocrinology" meeting

Procter & Gamble (PG) Phase III Data Published for Once Monthly Dose of Risedronate to Treat Postmenopausal Osteoporosis (BioSpace, 14 January 2008)

14 Jan 2008

Procter & Gamble have published the results from a Phase III clinical trial evaluating the efficacy and safety of risedronate 150 mg once monthly for the treatment of postmenopausal osteoporosis.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read